Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06776991 · ClinicalTrials.gov registry record · NA
Reward Processing and Exposure Therapy for Social Anxiety Disorder
A NA study of Anhedonia and Phobic Disorders, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 2
- Study locations
NCT06776991: Recruiting NA study of Anhedonia and Phobic Disorders, sponsored by University of California, Los Angeles.
NCT06776991 is a NA study of Anhedonia and Phobic Disorders that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 94 participants, below the 106-participant average among 21 other Anhedonia trials with a reported enrollment target (11% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06776991, a NA study of Anhedonia and Phobic Disorders, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators are conducting a clinical trial of therapy for public speaking anxiety. There are many eligibility criteria, but the main ones are that participants need to be socially anxious and have public speaking anxiety. In this clinical trial, all participants will do exposure therapy. Before doing exposure therapy in the study, though, participants will be randomized to do one of two treatments: i) a positive mood treatment, which is designed to increase how positive people feel, and ii) a relaxation treatment, which is designed to help people feel more relaxed. The investigators are doing this study to see whether doing the positive mood treatment or relaxation treatment first will affect how well exposure therapy works.
Primary Outcome
Self-reported public speaking anxiety symptom severity. This measure is a 17-item questionnaire using a 1-5 scale (1 = not at all, 3 = moderately, 5 = extremely) with sum scores ranging 17-83. Higher = worse.
Conditions Studied
Interventions
- BEHAVIORAL Exposure Therapy
- BEHAVIORAL Positive Affect Treatment - Behavioral (PAT-B)
- BEHAVIORAL Relaxation Treatment
Study Locations (2)
California
- University of California, Los Angeles - Los Angeles
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2024-09-26 |
| Est. Completion | 2029-04-30 |
| Phase | NA |
What NCT06776991 shows while recruiting
NCT06776991 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 106-participant average among 21 other Anhedonia trials with a reported enrollment target (11% lower).
The record links to 5 conditions, with Anhedonia appearing as the primary indexed condition, and to 3 interventions - of which Exposure Therapy is the first listed.
NCT06776991 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06776991 about?
NCT06776991 is a clinical study titled "Reward Processing and Exposure Therapy for Social Anxiety Disorder". The investigators are conducting a clinical trial of therapy for public speaking anxiety. There are many eligibility criteria, but the main ones are that participants need to be socially anxious and have public speaking anxiety. In this clinical trial, all participants will do exposure therapy. Befo...
What is the current status of trial NCT06776991?
This trial is currently recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2024-09-26. Estimated completion is 2029-04-30.
What conditions does trial NCT06776991 study?
This clinical trial studies the following conditions: Anhedonia, Phobic Disorders, Public Speaking Anxiety, Social Anxiety Disorder (Social Phobia), ANXIETY DISORDERS (or Anxiety and Phobic Neuroses).
What interventions are being tested in trial NCT06776991?
The interventions under investigation include: Exposure Therapy (BEHAVIORAL), Positive Affect Treatment - Behavioral (PAT-B) (BEHAVIORAL), Relaxation Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06776991?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06776991 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anhedonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06776991's enrollment target sits among peer trials
94 9th of 21 higher than 13 of 21 other Anhedonia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anhedonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
RECRUITING · NA
-
Get ActivE Study for At-risk Youth
RECRUITING · NA
-
Psychotherapy Effects on Reward Processing in PTSD
RECRUITING · NA
-
Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
RECRUITING · NA
-
Geolocation Positional System (GPS) Experience
RECRUITING · NA
-
Stress Trajectories and Anhedonia in Adolescence Research Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI